We have located links that may give you full text access.
Journal Article
Review
Intrastromal corneal ring technology: results and indications.
Current Opinion in Ophthalmology 1998 August
Intracorneal ring technology has shown rapid development in the past 10 years, and clinical results are confirming outstanding results for the correction of low to moderate refractive myopias. Two of these device designs, the Intrastromal Corneal Ring and the Intrastromal Corneal Ring Segments (both manufactured by KeraVision, Inc., Fremont, CA) are currently undergoing rigorous investigation in US Food and Drug Administration-regulated clinical trials. Results to date indicate the surgical procedure is safe and easily performed, the visual results are excellent (preserving best spectacle-corrected visual acuity), and the procedure provides stable and predictable correction through several years postoperatively. Preliminary results show that enhancements can be easily performed by device exchange, and the device can be removed, reversing the refractive effect.
Full text links
Related Resources
Trending Papers
Systemic lupus erythematosus.Lancet 2024 April 18
Should renin-angiotensin system inhibitors be held prior to major surgery?British Journal of Anaesthesia 2024 May
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app